Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer.
Ikeuchi N, Igata F, Kinoshita E, Kawabata T, Tan I, Osaki Y, Otsuka R, On R, Ikeda T, Nakao A, Sasaki T, Aoyama T, Hirano R, Harada T, Ebi N, Fujita M, Inoue H. Ikeuchi N, et al. Among authors: inoue h. Anticancer Res. 2023 Feb;43(2):713-724. doi: 10.21873/anticanres.16210. Anticancer Res. 2023. PMID: 36697078
Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors.
Tsutsumi H, Inoue H, Shiraishi Y, Hirayama A, Nakanishi T, Ando H, Nakajima M, Shinozaki S, Ogata H, Okamura K, Kimura S, Ogawa T, Ota K, Yoneshima Y, Tanaka K, Hamada N, Okamoto I, Iwama E. Tsutsumi H, et al. Among authors: inoue h. Lung Cancer. 2023 Jul;181:107264. doi: 10.1016/j.lungcan.2023.107264. Epub 2023 Jun 2. Lung Cancer. 2023. PMID: 37276707
Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG).
Takimoto R, Kamigaki T, Ito H, Saito M, Takizawa K, Soejima K, Yasuda H, Ohgino K, Terai H, Tomita K, Miura M, Mizukoshi E, Miyashita T, Nakamoto Y, Hayashi K, Miwa S, Kitahara M, Takeuchi A, Kimura H, Mochizuki T, Sugie H, Seino KI, Yamada T, Takeuchi S, Makita K, Naitoh K, Yasumoto K, Yoshida Y, Inoue H, Kotake K, Ohshima K, Noda SE, Okamoto M, Yoshimoto Y, Okada S, Ibe H, Oguma E, Goto S; CITEG. Takimoto R, et al. Among authors: inoue h. Cytotherapy. 2023 Nov;25(11):1229-1235. doi: 10.1016/j.jcyt.2023.06.007. Epub 2023 Jul 22. Cytotherapy. 2023. PMID: 37486281 Free article.
Gastric intramural metastasis caused by needle tract seeding after preoperative fine needle aspiration for pancreatic body cancer subsequently resected by total pancreatectomy: a case report and literature review.
Yoshida E, Kimura Y, Kyuno T, Kawagishi R, Sato K, Kono T, Chiba T, Kimura T, Yonezawa H, Funato O, Kobayashi M, Keira Y, Onuma K, Inoue H, Takagane A, Takemasa I. Yoshida E, et al. Among authors: inoue h. World J Surg Oncol. 2023 Feb 13;21(1):44. doi: 10.1186/s12957-023-02914-0. World J Surg Oncol. 2023. PMID: 36782222 Free PMC article. Review.
Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and China.
Qi J, Choi I, Ota S, Ichikawa S, Fujishima N, Iida H, Sugiura I, Sugiura K, Murata Y, Inoue H, Ohwada S, Wang J. Qi J, et al. Among authors: inoue h. Clin Pharmacol Drug Dev. 2024 May;13(5):560-571. doi: 10.1002/cpdd.1353. Epub 2024 Jan 29. Clin Pharmacol Drug Dev. 2024. PMID: 38284515 Clinical Trial.
Distinctive histopathologic findings of pancreatic hamartomas suggesting their "hamartomatous" nature: a study of 9 cases.
Yamaguchi H, Aishima S, Oda Y, Mizukami H, Tajiri T, Yamada S, Tasaki T, Yamakita K, Imai K, Kawakami F, Hara S, Hanada K, Iiboshi T, Fukuda T, Imai H, Inoue H, Nagakawa T, Muraoka S, Furukawa T, Shimizu M. Yamaguchi H, et al. Among authors: inoue h. Am J Surg Pathol. 2013 Jul;37(7):1006-13. doi: 10.1097/PAS.0b013e318283ce4c. Am J Surg Pathol. 2013. PMID: 23715157
Legionella uses host Rab GTPases and BAP31 to create a unique ER niche.
Chadha A, Yanai Y, Oide H, Wakana Y, Inoue H, Saha S, Tagaya M, Arasaki K, Mukherjee S. Chadha A, et al. Among authors: inoue h. bioRxiv [Preprint]. 2024 May 12:2024.05.10.593622. doi: 10.1101/2024.05.10.593622. bioRxiv. 2024. PMID: 38765994 Free PMC article. Preprint.
6,443 results